We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Impact Healthcare Reit Plc | LSE:IHR | London | Ordinary Share | GB00BYXVMJ03 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.70 | -0.83% | 83.30 | 82.80 | 83.00 | 83.50 | 81.20 | 81.20 | 576,940 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Investment Trust | 42.95M | 16.89M | 0.0408 | 20.29 | 343.1M |
TIDMIHR
RNS Number : 7789Z
Impact Healthcare REIT PLC
17 May 2023
17 May 2023
Impact Healthcare REIT plc
("Impact" or the "Company")
Result of 2023 Annual General Meeting
The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, announces that at the Company's 2023 Annual General Meeting held today, all resolutions proposed at the AGM were voted on and passed by a poll by the Company's shareholders and the results of the poll, including the proxy votes received, are set out below.
Resolutions 1 to 12 (inclusive) were proposed as ordinary resolutions and resolutions 13 to 16 (inclusive) were proposed as special resolutions.
Resolution Votes For* % Votes Against % Total votes Total votes Votes Withheld validly cast cast as % of ** issued share capital Receive the Annual Report and Financial Statements Year 31 1 December 2022 281,210,111 100.00% 0 0.00% 281,210,111 67.86% 226,521 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Approve the 281,154,070 99.96% 115,981 0.04% 281,270,051 67.88% 166,581 directors' remuneration 2 report -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Approve the Company's Dividend 3 Policy 281,387,092 100.00% 0 0.00% 281,387,092 67.91% 49,540 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Re-elect Rosemary Boot 4 as a director 278,046,424 98.81% 3,343,574 1.19% 281,389,998 67.91% 46,634 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Re-elect Philip Hall 5 as a director 278,055,966 98.81% 3,334,922 1.19% 281,390,888 67.91% 45,744 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Re-elect Amanda Aldridge as a 6 director 279,416,802 99.30% 1,974,086 0.70% 281,390,888 67.91% 45,744 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Re-elect Chris Santer 7 as a director 279,425,480 99.30% 1,965,408 0.70% 281,390,888 67.91% 45,744 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Elect Simon Laffin as a 8 director 281,388,218 100.00% 2,670 0.00% 281,390,888 67.91% 45,744 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- To re-appoint 276,383,577 100.00% 5,434 0.00% 276,389,011 66.70% 5,047,621 BDO LLP as the Company's 9 auditor -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- To authorise 281,388,454 100.00% 2,434 0.00% 281,390,888 67.91% 45,744 the board of directors to determine the auditors 10 remuneration -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- To authorise 281,279,879 99.96% 104,277 0.04% 281,384,156 67.91% 48,680 the Directors to allot shares under section 551 Companies Act 11 2006 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Subject to 281,251,968 99.95% 138,920 0.05% 281,390,888 67.91% 45,744 the passing of resolution 11, to authorise the Directors to allot additional shares under section 551 Companies 12 Act 2006 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Subject to 280,589,017 99.72% 798,935 0.28% 281,387,952 67.91% 48,680 the passing of resolution 11, to disapply statutory pre-emption rights under section 570 Companies 13 Act 2006 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- Subject to 274,009,998 97.38% 7,377,954 2.62% 281,387,952 67.91% 48,680 the passing of resolution 12, to disapply statutory pre-emption rights under section 570 Companies 14 Act 2006 -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- To authorise 273,102,300 97.07% 8,240,537 2.93% 281,342,837 67.90% 93,795 the Company to make market purchase of its own ordinary 15 shares -------------- ------------ -------- -------------- ------ --------------- --------------- --------------- To permit 274,651,335 97.60% 6,739,553 2.40% 281,390,888 67.91% 45,744 general meetings to be called on 14 days' 16 notice -------------- ------------ -------- -------------- ------ --------------- --------------- ---------------
Every shareholder has one vote for every Ordinary Share held. As at close of business on 17 May 2023, the share capital of the Company consisted of 414,368,169 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury.
In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
* Includes discretionary votes.
** A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP via Maitland/AMO Mahesh Patel Andrew Cowley JTC (UK) Limited - Company Secretary 0207 409 0181 Susan Fadil Impact.CoSec@jtcgroup.com Maitland/AMO (Communications 07747 113 930 Adviser) i mpact health-maitland@maitland.co.uk James Benjamin
The Company's LEI is 213800AX3FHPMJL4IJ53.
NOTES
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.
The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.
The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.
On this basis, the target total dividend for the year ending 31 December 2023 is 6.77 pence per share(3) , a 3.53% increase over the 6.54 pence in dividends paid or declared per ordinary share for the year ended 31 December 2022.
The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.
(3) This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGARMATMTIBBRJ
(END) Dow Jones Newswires
May 17, 2023 11:49 ET (15:49 GMT)
1 Year Impact Healthcare Reit Chart |
1 Month Impact Healthcare Reit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions